Emergent BioSolutions | EBS - Capitalisation Boursière





Capitalisation Boursière Changement Date
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
ALKERMES USD 5.88B 1.26B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.75B 24M 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Exelixis USD 10.89B 857M 2026-03
Glaxosmithkline GBP 108.55B 736M 2026-07
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Pacira USD 915M 149M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03
Vanda Pharmaceuticals USD 279M 6M 2024-12